Goeman CJ. The Price Isn’t Right: Shareholder Proposals as Opportunities for Institutional Investors to Restore Firm Value and Reduce Pharmaceutical Prices. CBLR [Internet]. 2017 Aug. 11 [cited 2024 Jul. 18];2017(2):748-806. Available from: https://journals.library.columbia.edu/index.php/CBLR/article/view/1723